| Literature DB >> 35032010 |
Caroline Cao1, Nisha Jain1, Elaine Lu1, Martha Sajatovic2, Carolyn Harmon Still3.
Abstract
OBJECTIVE: To address the fact that Black adults (BAs) experience significantly greater stroke burden than the general population, we conducted a systematic literature review which described evidence-based interventions targeting secondary stroke risk reduction in BAs. DATA SOURCE: Publications were selected from PubMed, Ovid, Cochrane, and Web of Science databases. We included peer-reviewed, longitudinal, English-language studies performed in the USA which reported results for BAs separately and had adult participants who had experienced stroke-related events.Entities:
Keywords: Black adults; Cardiovascular risk; Health disparities; Risk reduction; Secondary stroke; Stroke
Year: 2022 PMID: 35032010 PMCID: PMC8759598 DOI: 10.1007/s40615-021-01221-2
Source DB: PubMed Journal: J Racial Ethn Health Disparities ISSN: 2196-8837
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| • English language literature | • Opinion pieces/editorials |
| • Original research reports | • Other literature reviews |
| • Studies done in the USA | • Book chapters |
| • Humans only | • Papers which only describe research methods but lack any elements of intervention |
| • Interventional or cohort studies | • Cross-sectional studies |
| • Adult samples age 18 or older; mixed samples if adults are reported separately | • Studies on acute stroke management (within 7 days of stroke) |
| • Studies with a Black American sample; studies with diverse samples with the Black American sub-sample specifically identified | • Studies focused on stroke due to sickle cell disease or other genetic coagulopathies appearing in childhood |
| • Secondary stroke risk reduction |
Fig. 1Flow diagram of studies
Adapted Newcastle–Ottawa Quality Assessment Scale
| Representativeness of the sample | |
| 0 | No description of sampling strategy |
| 1 | Sample included only a select group of individuals (select type of stroke, e.g., TIA) |
| 2 | Somewhat representative (inpatient sample) |
| 3 | Somewhat representative (outpatient sample) |
| 4 | Truly representative (database or epidemiological study) |
| Ascertainment of exposure (history of previous stroke) | |
| 0 | Self-report |
| 1 | Medical record |
| 2 | Medical record that was reviewed and confirmed |
| Selection of intervention and control groups | |
| 0 | No control (e.g., case series, cohort) |
| 1 | Case–control |
| 2 | Randomized-controlled trial |
| Comparability of groups | |
| 0 | No groups, or no matching of subjects |
| 1 | Subjects of the groups were comparable, as determined by the matching of demographic factors |
| Assessment of outcome | |
| 0 | Inadequate and/or not justified |
| 1 | Justified and satisfactory |
| Sample size | |
| 0 | Not justified |
| 1 | Adequately powered to detect a difference |
| 2 | Justified and satisfactory |
Summary of goal, study design, sample size, demographics, primary outcomes, and quality of included reports
| Citation (year) | Goal | Study Design | Sample and previous stroke-related event | Mean age | Female (%) | Proportion of BA participants (%) | Primary outcome and additional stroke-related outcomes | Adapted Newcastle–Ottawa Quality Assess-ment Scale |
|---|---|---|---|---|---|---|---|---|
| Cheng et al. [ | To test the efficacy of a chronic care model-based intervention compared to usual care in reducing stroke risk among vulnerable ischemic or transient ischemic stroke survivors | RCT of intervention vs. control, followed up for 1 year | 404 Intervention 204 Control 200 TIA or ischemic stroke within 90 days prior to the start of the study | 57 | 39.7 | 14.6 | Primary: Change in SBP Other: LDL reduction, antithrom-botic medication use, smoking cessation, physical activity | 11 |
| Sajato-vic et al. [ | To test the efficacy of a novel self-management treatment compared to usual care in reducing stroke risk in BA male stroke survivors | RCT followed up for 6 months | 38 Intervention 19 Control 19 Previous stroke or TIA; start of study within 12 months of hospital dis-charge or release from Emergency Department | 52 | 0.0 | 100.0 | Primary: Change in self-reported medication adherence Other: Blood pressure, HbA1c, lipids, weight, standardized measures of health behavior (diet, exercise, smoking, substances), depression, quality of life, qualitative evaluations of the perspective of TEAM participants | 9 |
| Boden-Albala et al. [ | To test the efficacy of a culturally tailored skills-based educational intervention compared to usual care in reducing stroke risk a multiethnic cohort of patients with mild/moderate strokes/TIAs | RCT followed up for 1 year | 552 Intervention 271 Control 281 Presentation or transfer to an enrolling site (medical centers in NYC) with a diagnosis of TIA, IS, or ICH within NIHSS < 5 at enroll-ment | 65 | 50.9 | 33.1 | Primary: Change in SBP Other: risk factors and outcome events of stroke, risk factors and outcome events of MI, risk factors and outcomes of vascular death | 10 |
| Gorelick et al. [ | To test the efficacy and safety of aspirin and ticlopidine in preventing recurrent stroke in BAs | RCT followed up for 2 years | 1809 Ticlopidine 902 Aspirin 907 Noncardioembolic ischemic stroke within onset at least 7 days but not more than 90 days prior to start of study | 61 | 53.5 | 100.0 | Primary: Composite end point of recurrent stroke, MI, or vascular death Other: fatal or nonfatal stroke | 11 |
| Rimmer et al. [ | To test the efficacy of a 12-week exercise training program in reducing stroke risk factors in BA stroke survivors | Lag-control Group Design with each iteration lasting 12 weeks | 35 First iteration 18 Second iteration 17 Post-stroke at least 6 months prior to start of study | 53 | 74.3 | 88.6 | Primary: Peak VO2, maximal workload, time to exhaustion, overall strength, grip strength, body weight, total skinfolds, waist to hip ratio, hamstring/low back flexibility, shoulder flexibility Other: none | 8 |
| Rimmer et al. [ | To test the efficacy of a 12-week exercise health promotion intervention in reducing stroke risk factors in BA stroke survivors | Lag-control Group Design with each iteration lasting 12 weeks | 35 First iteration 18 Second iteration 17 Post-stroke at least 6 months prior to start of study | 53 | 74.3 | 88.6 | Primary: Lipid profiles, exercise ability, nutrition Other: none | 8 |
| Feldman et al. [ | To test the efficacy of a transitional care model aimed at controlling hypertension in BA and Hispanic stroke survivors receiving home health care | RCT followed up for 12 months | 495 Interven-tion I 165 Intervention II 165 Control 165 First-time or recurrent TIA at any point prior to start of study | 66 | 57.0 | 69.7 | Primary: Change in SBP Other: none | 11 |
| Kronish et al. [ | To test the efficacy of peer education in secondary stroke prevention among predominantly minority stroke survivors | RCT followed up for 6 months | 600 Intervention 301 Control 299 Reported occurrence of stroke or “mini stroke” (ex. TIA) within 5 years prior to start of study | 63 | 59.5 | 41.4 | Primary: Proportion of participants with a composite of controlled BP (< 140/90 mm Hg), LDL cholesterol < 100 mg/dL, and use of antithrombotics Other: control of individual stroke risk factors | 9 |
Note. RCT randomized control trial, SBP systolic blood pressure, BA Black American, TIA transient ischemic attack, IS ischemic stroke, ICH intracranial hemorrhage, MI myocardial infarction,VO2 rate of oxygen consumption, LDL low-density lipoprotein
Summary of interventions and major findings of included studies
| Citation (year) | Description of intervention | Major findings |
|---|---|---|
| Cheng et al. (2018) [ | • Regular clinical care with a NP/PA care manager at 1 and 7 months post-enrollment. NP/PA care manager monitors stroke risk factors (tobacco cessation, physical activity, depression, medication adherence). Report cards given after each clinical visit. Each of these sessions was scheduled for 1 h | No significant difference between the chronic-care based intervention arm compared to the usual care arm among the student participants as a whole. SBP decreased by 17.3 mm Hg in their intervention arm and 13.7 mm Hg in their control arm after 12 months (− 3.6 mm Hg (95% CI (9.3,2.2)). BA participants experienced a significantly greater decrease in SBP in the intervention arm than the usual care arm |
| • Participants attend group clinics at 2, 5, and 10 months post-enrollment. Each of these sessions was scheduled for 2 h, but in total, 8 h was devoted to group work (including scheduling and coordinating) | ||
| • At home blood pressure monitoring | ||
| Sajatovic et al. (2018) [ | • One 60-min 1:1 session between participants, their care partner, and a Nurse Educator. Four 60-min group sessions with 4–7 other participants and their caretakers. Seven short 10–20-min telephone sessions which correspond with the other sessions. Intervention as a whole lasts 6 months | No significant difference in self-reported medication adherence between the two groups. Those in the self-management based intervention arm had significantly lower SBPs than the usual care group after 6 months ( |
| • All sessions focused on 1) patient and care partner needs, 2) problem-solving practice, and 3) attention to emotional and role management | ||
| Boden-Albala et al. (2019) [ | • Participants engaged in an interactive educational session with a community health educator prior to discharge | No significant difference in SBP reduction between the two groups ( |
| • Participants received a patient-paced workbook and video emphasizing 1) patient-physician communication, 2) medication adherence, 3) accurate stroke risk perception with risk reduction skills | ||
| • Care coordinator conducted follow-up calls at 72 h, 1 month, and 3 months post-discharge to enhance the themes of the workbook | ||
| • All participants, including controls, had in-person follow-ups to assess stroke risk factors at 6 and 12 months | ||
| Gorelick et al. (2003) [ | • Participants either received 650 mg/day of Ticlopidine or 500 mg/day of Aspirin | No significant difference between the medications in preventing the composite primary end-point of recurrent stroke, MI, or vascular death |
| Rimmer et al. (2000) [ | • 12-week program that occurs 3 days/week. Programming targeted the domains of exercise, nutrition, education, and health behavior change. Each day of programming involved 1 h of exercise, a 1-h class on nutrition led by a registered dietician. Health behavior classes met for 60–90 min 2–3 days/week; classes were led by a psychologist, social worker, and/or registered nurse | The intervention group made significant gains over the controls in reduction of total cholesterol, cardiovascular fitness, increased strength and flexibility, and greater life satisfaction |
| Feldman et al. (2020) [ | • 2 types of interventions | Across all 3 groups, there was a 9–10 mm Hg decline in SBP at the 1-year follow-up. The majority of this decline occurred within the first 3 months post-discharge, but was maintained for the entire year. Among the BA participants, the UHC + NP group exhibited significantly greater decline in SBP compared to the other 2 groups ( |
| • Usual Home Care (UHC) + NP: NP led a 30-day transitional care program involving 3 in-home visits and 3 patient/caregiver telephone contacts. These visits involved helping participants communicate with their other health care providers, monitoring participants health, and creating culturally sensitive self-management plans | ||
| • UHC + NP + Health Coach (HC): all the interventions the UHC + NP group received as well as 60 days of support from a HC. This protocol added 3 in-home visits and 3 telephone contacts. The HC promoted risk factor awareness, supported self-management, and facilitated patient re-integration into their community | ||
| Kronish et al. (2013) [ | • 6 weeks of weekly 90-min peer education workshops. Each workshop involved group work between 9 and 10 participants, and workshops were led by 2 peer leaders with similar socioeconomic backgrounds and health conditions as the participants. Workshops focused on explaining the biology of stroke and stroke treatments, stressing the importance of medication adherence, providing suggestions for how to improve medication adherence and communication with healthcare teams, and creating an action plan | There was no difference in the composite outcome between the intervention and control group. At 6 months, the proportion of individuals with controlled BP was significantly greater in the intervention than the control group (− 3.63 SD 19.81 mm Hg versus + 0.34 SD 23.76 mm Hg, |
Note. NP nurse practitioner, PA physician’s assistant, SBP systolic blood pressure, MI myocardial infraction, BMI body mass index, BA Black American